This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Solomon, J. M.
Right arrow Articles by Huber, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Solomon, J. M.
Right arrow Articles by Huber, L. J.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, January 2006, p. 28-38, Vol. 26, No. 1
0270-7306/06/$08.00+0     doi:10.1128/MCB.26.1.28-38.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Inhibition of SIRT1 Catalytic Activity Increases p53 Acetylation but Does Not Alter Cell Survival following DNA Damage

Jonathan M. Solomon, Rao Pasupuleti, Lei Xu, Thomas McDonagh, Rory Curtis, Peter S. DiStefano, and L. Julie Huber*

Elixir Pharmaceuticals, Inc., One Kendall Square, Cambridge, Massachusetts 02139

Received 16 May 2005/ Returned for modification 5 July 2005/ Accepted 3 October 2005

Human SIRT1 is an enzyme that deacetylates the p53 tumor suppressor protein and has been suggested to modulate p53-dependent functions including DNA damage-induced cell death. In this report, we used EX-527, a novel, potent, and specific small-molecule inhibitor of SIRT1 catalytic activity to examine the role of SIRT1 in p53 acetylation and cell survival after DNA damage. Treatment with EX-527 dramatically increased acetylation at lysine 382 of p53 after different types of DNA damage in primary human mammary epithelial cells and several cell lines. Significantly, inhibition of SIRT1 catalytic activity by EX-527 had no effect on cell growth, viability, or p53-controlled gene expression in cells treated with etoposide. Acetyl-p53 was also increased by the histone deacetylase (HDAC) class I/II inhibitor trichostatin A (TSA). EX-527 and TSA acted synergistically to increase acetyl-p53 levels, confirming that p53 acetylation is regulated by both SIRT1 and HDACs. While TSA alone reduced cell survival after DNA damage, the combination of EX-527 and TSA had no further effect on cell viability and growth. These results show that, although SIRT1 deacetylates p53, this does not play a role in cell survival following DNA damage in certain cell lines and primary human mammary epithelial cells.


* Corresponding author. Mailing address: Elixir Pharmaceuticals, Inc., One Kendall Square, Cambridge, MA 02139. Phone: (617) 995-7007. Fax: (617) 995-7050. E-mail: jhuber{at}elixirpharm.com.


Molecular and Cellular Biology, January 2006, p. 28-38, Vol. 26, No. 1
0022-538X/06/$08.00+0     doi:10.1128/MCB.26.1.28-38.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Xie, Y.-B., Park, J.-H., Kim, D.-K., Hwang, J. H., Oh, S., Park, S. B., Shong, M., Lee, I.-K., Choi, H.-S. (2009). Transcriptional Corepressor SMILE Recruits SIRT1 to Inhibit Nuclear Receptor Estrogen Receptor-related Receptor {gamma} Transactivation. J. Biol. Chem. 284: 28762-28774 [Abstract] [Full Text]  
  • Jung-Hynes, B., Ahmad, N. (2009). SIRT1 controls circadian clock circuitry and promotes cell survival: a connection with age-related neoplasms. FASEB J. 23: 2803-2809 [Abstract] [Full Text]  
  • Kabra, N., Li, Z., Chen, L., Li, B., Zhang, X., Wang, C., Yeatman, T., Coppola, D., Chen, J. (2009). SirT1 Is an Inhibitor of Proliferation and Tumor Formation in Colon Cancer. J. Biol. Chem. 284: 18210-18217 [Abstract] [Full Text]  
  • Ellis, L., Atadja, P. W., Johnstone, R. W. (2009). Epigenetics in cancer: Targeting chromatin modifications. Molecular Cancer Therapeutics 8: 1409-1420 [Abstract] [Full Text]  
  • Gatz, S. A., Wiesmuller, L. (2008). Take a break--resveratrol in action on DNA. Carcinogenesis 29: 321-332 [Abstract] [Full Text]